ELF3 and lung carcinoma: By integrating the clinical analyses and genetic mouse models, we found that ELF3 overexpression in the PTEN-deficient background promoted cell proliferation and inhibited ferroptosis by inducing SLC7A11 expression, thus promoting lung cancer development.